PartnershipUpdated on 18 June 2026
Pharmaceutical partnerships for innovative addiction medicines
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
About
MFD is looking for pharmaceutical and biotech partners interested in collaborating on the development of cannabis-based medicines for addiction treatment.
MFD is developing cannabis medicated chewing gums designed to support behavioural therapies by helping patients manage anxiety peaks and craving during addiction treatment.
The technology is based on a pharmaceutical-grade, single-dose oral dosage form with controlled delivery through the buccal mucosa. It may be applied to different addiction-related indications, including Cannabis Use Disorder (CUD), alcohol dependence, cocaine dependence and opioid dependence.
We are open to different partnership models, including co-development, clinical expansion, regulatory development, licensing discussions and strategic pharma alliances.
Looking for
- Development
- Others
Organisation
Similar opportunities
Product
Cannabis medicated chewing gums for addiction treatment
- Health innovation
- Distribution Partner
- Pharmaceutical industry
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Project cooperation
Clinical and research collaborations in addiction treatment
- Planning
- Research
- Financing
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Investment
Investment opportunity in cannabis medicines for addiction treatment
- Healthcare
- Seed and Development
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain